Active, not recruitingNCT03651505
X-linked Hypophosphatemia Disease Monitoring Program
Studying X-linked hypophosphatemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Ultragenyx Pharmaceutical Inc
- Principal Investigator
- Ultragenyx Medical DirectorUltragenyx Pharmaceuticals Inc.
- Intervention
- No intervention(other)
- Enrollment
- 782 enrolled
- Eligibility
- All sexes
- Timeline
- 2018 – 2032
Study locations (30)
- Children's Hospital of Alabama, Birmingham, Alabama, United States
- Children's Hospital Los Angeles, Los Angeles, California, United States
- Rady Children's Hospital San Diego, San Diego, California, United States
- University of California San Francisco, San Francisco, California, United States
- Children's Hospital of Colorado, Aurora, Colorado, United States
- Yale University School of Medicine, New Haven, Connecticut, United States
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
- Indiana University School of Medicine, Indianapolis, Indiana, United States
- Johns Hopkins University, Baltimore, Maryland, United States
- Boston Children's Hospital, Boston, Massachusetts, United States
- Washington University School of Medicine, St Louis, Missouri, United States
- Duke University, Durham, North Carolina, United States
- Cincinnati Children's Hospital, Cincinnati, Ohio, United States
- Nationwide Children's Hospital, Columbus, Ohio, United States
- The Ohio State University Wexner Medical Center, Columbus, Ohio, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
Kyowa Kirin Co., Ltd.
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03651505 on ClinicalTrials.govOther trials for X-linked hypophosphatemia
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT06525636A First-in-human Study of KK8123 in Adults With X-linked HypophosphatemiaKyowa Kirin Co., Ltd.
- ACTIVE NOT RECRUITINGNCT04946409Burden of Disease and Functional Impairment in XLHWuerzburg University Hospital
- ACTIVE NOT RECRUITINGEARLY PHASE1NCT03748966Calcitriol Monotherapy for X-Linked HypophosphatemiaMassachusetts General Hospital
- ACTIVE NOT RECRUITINGNCT03745521Study of Longitudinal Observation for Patient With X-linked Hypophosphatemic Rickets/Osteomalacia in Collaboration With Asian PartnersKyowa Kirin Co., Ltd.
- RECRUITINGNCT03193476Registry for Patients With X-Linked HypophosphatemiaKyowa Kirin Pharmaceutical Development Ltd